New Key Statistics Module, Z-Score and F-Score
AMEX:IGC Key Ratios
Market Cap $ M | 34.42 |
Enterprise Value $ M | 33.12 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.14 |
Price/Sales | 19.78 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -0.22 |
Beneish M-Score | -4.73 |
10-y EBITDA Growth Rate % | -3.40 |
5-y EBITDA Growth Rate % | -5.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.38 |
EV-to-EBITDA | -3.61 |
PEG | -- |
Shares Outstanding M | 75.64 |
Net Margin (%) | -966.54 |
Operating Margin % | -728.48 |
Pre-tax Margin (%) | -966.54 |
Quick Ratio | 0.93 |
Current Ratio | 1.58 |
ROA % (ttm) | -92.18 |
ROE % (ttm) | -110.95 |
ROIC % (ttm) | -86.94 |
Dividend Yield % | -- |
Altman Z-Score | -12.21 |
IGC Number of Guru Trades
IGC Volume of Guru Trades
Gurus Latest Trades with AMEX:IGC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:IGC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
IGC Pharma Inc Insider Transactions
No Available Data
News about AMEX:IGC
Total 0- 1